首页> 外文期刊>International journal of laboratory hematology >Hirudin-induced pseudothrombocytopenia in a patient with EDTA-dependent platelet aggregation: report of a new laboratory artefact.
【24h】

Hirudin-induced pseudothrombocytopenia in a patient with EDTA-dependent platelet aggregation: report of a new laboratory artefact.

机译:水rud素诱导的EDTA依赖性血小板凝集患者的假性血小板减少症:新实验室假象的报告。

获取原文
获取原文并翻译 | 示例
           

摘要

Sir, anticoagulant-induced pseudothrombocytopenia (PTP) is an important cause of spuriously low platelet counts described for all haematology analysers used in clinical routine diagnostics. If misinterpreted, it may lead to serious diagnostical and therapeutical consequences like bone marrow biopsy, initiation of corticosteroid therapy, platelet transfusion or even splenectomy (Zandecki et al, 2007). PTP has been reported for different anticoagulants such as ethylenediamine tetra-acetic acid (EDTA), citrate, heparin and oxalate, occurring with an incidence of 0.1-0.2% for EDTA, which is the most commonly used agent for automated blood counts (Schrezenmeier et al, 1995).
机译:主席先生,抗凝诱导的假性血小板减少症(PTP)是导致临床常规诊断中使用的所有血液分析仪描述的血小板计数虚假降低的重要原因。如果被误解,则可能导致严重的诊断和治疗后果,例如骨髓活检,开始使用糖皮质激素治疗,血小板输注甚至脾切除术(Zandecki等,2007)。已经报道了PTP用于不同的抗凝剂,例如乙二胺四乙酸(EDTA),柠檬酸盐,肝素和草酸盐,EDTA的发生率为0.1-0.2%,EDTA是自动血细胞计数最常用的试剂(Schrezenmeier等)等,1995)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号